Baseline total metabolic tumor volume (TMTV) application in Hodgkin lymphoma: a review article
- 2 February 2022
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical and Translational Imaging
- Vol. 10 (3), 273-284
- https://doi.org/10.1007/s40336-022-00481-0
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complicationsInsights into Imaging, 2015
- FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive ValueCancers, 2015
- Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin LymphomaJournal of Clinical Oncology, 2014
- Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphomaCancer Science, 2013
- Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCTBone Marrow Transplantation, 2013
- Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Insights into Imaging, 2012
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trialThe Lancet, 2012
- Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapyHaematologica, 2012
- Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's DiseaseThe New England Journal of Medicine, 2007